What is the Pediatric Endocrine Society afraid of? Apparently, the truth about transgender interventions on minors.
That’s the unmistakable conclusion after the PES denied Do No Harm senior fellow Dr. Daniel Weiss’s request to host a session at the group’s upcoming Annual Meeting. He asked to cover the most important topic in pediatric medicine: Children de-transitioning after experiencing the physical and mental health problems of gender transitions.
But that’s the last thing PES wants to talk about it. Remarkably, the society said in its denial letter that it “aimed to put together a program that covered all topic areas in pediatric endocrinology.” So why isn’t it discussing a pressing topic that directly affects children’s health?
It seems PES doesn’t want an honest and open discussion about the effects of transgender interventions on minors. These interventions — which include puberty blockers, opposite sex hormones, and surgeries — are often invasive and irreversible. As Do No Harm’s Chloe Cole has personally experienced, once a child endures these interventions, they often regret their decision. A growing number of people who as minors “identified” with a gender in spite of their biologic reality are now seeking to change back.
PES appears to be fearful of these facts. When Do No Harm set up a booth at the Endocrine Society’s annual meeting earlier this year, many endocrinologists expressed agreement with our opposition to transgender interventions on minors. The same thing would almost certainly happen at PES’s annual meeting.
The Pediatric Endocrine Society should be fighting for children’s health. Instead, it’s stifling discussion about a critical threat to children’s health. The organization should be ashamed. Its members and the children they treat deserve better.
Get up to speed with the threats facing healthcare – and how we’re protecting patients and physicians.
"*" indicates required fields